Teleflex (TFX) Competitors $115.87 -3.63 (-3.04%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$116.98 +1.10 (+0.95%) As of 08/1/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TFX vs. HOLX, BAX, MASI, GMED, ITGR, ATEC, ATRC, IART, SRDX, and OFIXShould you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include Hologic (HOLX), Baxter International (BAX), Masimo (MASI), Globus Medical (GMED), Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), Surmodics (SRDX), and Orthofix Medical (OFIX). These companies are all part of the "health care equipment" industry. Teleflex vs. Its Competitors Hologic Baxter International Masimo Globus Medical Integer Alphatec AtriCure Integra LifeSciences Surmodics Orthofix Medical Hologic (NASDAQ:HOLX) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Does the media favor HOLX or TFX? In the previous week, Hologic had 2 more articles in the media than Teleflex. MarketBeat recorded 29 mentions for Hologic and 27 mentions for Teleflex. Hologic's average media sentiment score of 0.92 beat Teleflex's score of 0.77 indicating that Hologic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hologic 11 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teleflex 6 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is HOLX or TFX more profitable? Hologic has a net margin of 13.79% compared to Teleflex's net margin of 6.31%. Hologic's return on equity of 19.69% beat Teleflex's return on equity.Company Net Margins Return on Equity Return on Assets Hologic13.79% 19.69% 10.82% Teleflex 6.31%15.08%8.85% Do analysts rate HOLX or TFX? Hologic presently has a consensus price target of $76.42, indicating a potential upside of 13.78%. Teleflex has a consensus price target of $141.57, indicating a potential upside of 22.18%. Given Teleflex's higher probable upside, analysts plainly believe Teleflex is more favorable than Hologic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hologic 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.47Teleflex 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable valuation & earnings, HOLX or TFX? Hologic has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHologic$4.03B3.71$789.50M$2.3728.34Teleflex$3.05B1.68$69.68M$4.2527.26 Which has more risk and volatility, HOLX or TFX? Hologic has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Do insiders and institutionals believe in HOLX or TFX? 94.7% of Hologic shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 1.9% of Hologic shares are owned by insiders. Comparatively, 1.4% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryHologic beats Teleflex on 13 of the 17 factors compared between the two stocks. Get Teleflex News Delivered to You Automatically Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TFX vs. The Competition Export to ExcelMetricTeleflexMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$5.28B$6.77B$5.47B$20.69BDividend Yield1.14%1.32%4.74%3.67%P/E Ratio27.2620.9428.6729.07Price / Sales1.6859.01422.2666.55Price / Cash4.7120.5035.4522.84Price / Book1.214.468.274.43Net Income$69.68M$174.54M$3.24B$994.22M7 Day Performance-1.17%-5.27%-3.63%-3.35%1 Month Performance-4.55%-3.94%4.40%-2.06%1 Year Performance-51.14%8.26%25.97%10.15% Teleflex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TFXTeleflex4.931 of 5 stars$115.87-3.0%$141.57+22.2%-50.9%$5.28B$3.05B27.2614,100Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastHOLXHologic4.8674 of 5 stars$63.990.0%$77.33+20.9%-19.3%$14.26B$4.03B27.007,063Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionBAXBaxter International4.7892 of 5 stars$27.78-0.4%$36.38+30.9%-39.0%$14.25B$10.64B-25.2538,000Trending NewsEarnings ReportAnalyst ForecastMASIMasimo3.6811 of 5 stars$154.47-2.5%$191.60+24.0%+43.4%$8.38B$2.09B-16.855,600Positive NewsUpcoming EarningsGMEDGlobus Medical4.863 of 5 stars$56.35-2.1%$91.09+61.7%-24.9%$7.63B$2.52B42.055,300Upcoming EarningsITGRInteger3.3205 of 5 stars$112.51-1.9%$146.25+30.0%-8.2%$3.93B$1.72B53.3211,000ATECAlphatec4.3219 of 5 stars$10.49-1.3%$18.13+72.8%+107.4%$1.53B$611.56M-9.12700Trending NewsAnalyst ForecastGap UpATRCAtriCure3.3155 of 5 stars$29.26-1.6%$50.67+73.2%+63.5%$1.45B$465.31M-36.121,300News CoverageEarnings ReportAnalyst ForecastIARTIntegra LifeSciences4.2444 of 5 stars$11.13-7.1%$18.63+67.3%-50.0%$864.93M$1.61B-29.294,396Trending NewsEarnings ReportGap UpSRDXSurmodics3.8284 of 5 stars$30.21-1.3%$43.00+42.3%-12.8%$431.97M$121.58M-21.73450OFIXOrthofix Medical2.251 of 5 stars$10.63-2.0%$21.50+102.3%-31.7%$416.49M$804.53M-2.881,616Upcoming Earnings Related Companies and Tools Related Companies Hologic Alternatives Baxter International Alternatives Masimo Alternatives Globus Medical Alternatives Integer Alternatives Alphatec Alternatives AtriCure Alternatives Integra LifeSciences Alternatives Surmodics Alternatives Orthofix Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TFX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teleflex Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Teleflex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.